A detailed history of Gsa Capital Partners LLP transactions in Insmed Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 5,151 shares of INSM stock, worth $367,060. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,151
Holding current value
$367,060
% of portfolio
0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$62.0 - $79.01 $319,362 - $406,980
5,151 New
5,151 $376,000
Q4 2023

Feb 16, 2024

BUY
$23.42 - $31.74 $716,581 - $971,148
30,597 Added 79.71%
68,984 $2.14 Million
Q3 2023

Nov 15, 2023

BUY
$19.86 - $26.93 $762,365 - $1.03 Million
38,387 New
38,387 $969,000
Q1 2023

May 12, 2023

BUY
$16.26 - $21.73 $323,378 - $432,166
19,888 Added 31.98%
82,072 $1.4 Million
Q4 2022

Feb 13, 2023

SELL
$16.98 - $23.15 $396,432 - $540,483
-23,347 Reduced 27.3%
62,184 $1.24 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $1.79 Million - $2.41 Million
85,531 New
85,531 $1.84 Million
Q2 2022

Aug 09, 2022

SELL
$17.07 - $25.71 $207,434 - $312,427
-12,152 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$20.42 - $28.13 $248,143 - $341,835
12,152 New
12,152 $286,000
Q2 2021

Aug 05, 2021

SELL
$24.17 - $36.01 $487,798 - $726,753
-20,182 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$32.28 - $44.3 $224,604 - $308,239
6,958 Added 52.62%
20,182 $687,000
Q4 2020

Feb 03, 2021

SELL
$31.45 - $40.54 $2.38 Million - $3.07 Million
-75,805 Reduced 85.15%
13,224 $440,000
Q3 2020

Nov 06, 2020

BUY
$26.0 - $34.5 $2.31 Million - $3.07 Million
89,029 New
89,029 $2.86 Million
Q4 2019

Feb 12, 2020

SELL
$16.12 - $24.98 $359,637 - $557,303
-22,310 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$15.49 - $25.78 $345,581 - $575,151
22,310 New
22,310 $394,000
Q2 2019

Aug 06, 2019

SELL
$23.0 - $32.19 $494,799 - $692,503
-21,513 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $299,245 - $670,129
21,513 New
21,513 $625,000
Q1 2018

May 11, 2018

SELL
$21.69 - $32.99 $429,982 - $653,993
-19,824 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$26.43 - $31.78 $80,082 - $96,293
3,030 Added 18.04%
19,824 $618,000
Q3 2017

Nov 20, 2017

BUY
$11.61 - $31.21 $194,978 - $524,140
16,794
16,794 $524,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.